AIM: We sought to discover endogenous urinary biomarkers of human CYP2D6 activity. PATIENTS & METHODS: Healthy pediatric subjects (n = 189) were phenotyped using dextromethorphan and randomized for candidate biomarker selection and validation. Global urinary metabolomics was performed using liquid chromatography quadrupole time-of-flight mass spectrometry. Candidate biomarkers were tested in adults receiving fluoxetine, a CYP2D6 inhibitor. RESULTS: A biomarker, M1 (m/z 444.3102) was correlated with CYP2D6 activity in both the pediatric training and validation sets. Poor metabolizers had undetectable levels of M1, whereas it was present in subjects with other phenotypes. In adult subjects, a 9.56-fold decrease in M1 abundance was observed during CYP2D6 inhibition. CONCLUSION: Identification and validation of M1 may provide a noninvasive means of CYP2D6 phenotyping.
AIM: We sought to discover endogenous urinary biomarkers of humanCYP2D6 activity. PATIENTS & METHODS: Healthy pediatric subjects (n = 189) were phenotyped using dextromethorphan and randomized for candidate biomarker selection and validation. Global urinary metabolomics was performed using liquid chromatography quadrupole time-of-flight mass spectrometry. Candidate biomarkers were tested in adults receiving fluoxetine, a CYP2D6 inhibitor. RESULTS: A biomarker, M1 (m/z 444.3102) was correlated with CYP2D6 activity in both the pediatric training and validation sets. Poor metabolizers had undetectable levels of M1, whereas it was present in subjects with other phenotypes. In adult subjects, a 9.56-fold decrease in M1 abundance was observed during CYP2D6 inhibition. CONCLUSION: Identification and validation of M1 may provide a noninvasive means of CYP2D6 phenotyping.
Authors: M J Blake; A Gaedigk; R E Pearce; L R Bomgaars; M L Christensen; C Stowe; L P James; J T Wilson; G L Kearns; J S Leeder Journal: Clin Pharmacol Ther Date: 2007-02-14 Impact factor: 6.875
Authors: Ursula Lutz; Nataly Bittner; Roman W Lutz; Werner K Lutz Journal: J Chromatogr B Analyt Technol Biomed Life Sci Date: 2008-05-03 Impact factor: 3.205
Authors: Timothy S Tracy; Amarjit S Chaudhry; Bhagwat Prasad; Kenneth E Thummel; Erin G Schuetz; Xiao-Bo Zhong; Yun-Chen Tien; Hyunyoung Jeong; Xian Pan; Laura M Shireman; Jessica Tay-Sontheimer; Yvonne S Lin Journal: Drug Metab Dispos Date: 2015-12-17 Impact factor: 3.922
Authors: Marissa G Baker; Christopher D Simpson; Yvonne S Lin; Laura M Shireman; Noah Seixas Journal: Ann Work Expo Health Date: 2017-05-01 Impact factor: 2.179
Authors: Marissa G Baker; Yvonne S Lin; Christopher D Simpson; Laura M Shireman; Susan Searles Nielsen; Brad A Racette; Noah Seixas Journal: J Trace Elem Med Biol Date: 2018-11-03 Impact factor: 3.849
Authors: Vasudev Kantae; Elke H J Krekels; Michiel J Van Esdonk; Peter Lindenburg; Amy C Harms; Catherijne A J Knibbe; Piet H Van der Graaf; Thomas Hankemeier Journal: Metabolomics Date: 2016-12-19 Impact factor: 4.290